2 results
Approved WMOCompleted
The purpose of the study is to investigate to what extent MMI-0100 is tolerated after multiple administrations.It will also be investigated how quickly and to what extent MMI-0100 is absorbed and eliminated from the body (this is called…
Approved WMORecruiting
Primary objectives:1) To determine whether concurrent ATII-antagonist treatment can prevent trastuzumab-related cardiotoxicity, defined as a decline in LVEF of more than 15% or a decrease to an absolute value <45%Secondary objectives:1) To…